Position in LXEO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$22,012,893
-$15,466,074 QoQ
Shares Held
3,834,999
+1.6% QoQ
Ownership
4.88%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXEO Over Time
Shares Held
Position Value (USD)
Derivatives in LXEO
reported options exposure · as of Mar 31, 2026CallValue
$61,418
CallShares
10,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026CITADEL ADVISORS LLC holds $5,784,241,435 across 374 Biotechnology names. LXEO ranks #58 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
2,182,571 | $356,894,009 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
1,032,298 | $306,561,536 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
4,512,634 | $254,918,694 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,259,444 | $238,097,887 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
453,843 | $237,573,195 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
3,173,940 | $235,696,783 | |
| 7 | TERN |
Terns Pharmaceuticals, Inc.
|
3,218,810 | $169,695,662 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
1,551,900 | $163,570,260 |
All Filings in LXEO
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,012,893 | 3,834,999 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $61,418 | 10,700 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $37,478,967 | 3,774,317 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $24,694,444 | 3,719,043 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $21,443,130 | 5,334,112 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $14,504,027 | 3,607,967 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $44,416 | 12,800 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $9,450,069 | 2,723,363 | Shares | Defined | 2025-05-15 | |
| 2025-03-31 | $347 | 100 | Call | Defined | 2025-05-15 | |
| 2024-12-31 | $17,919,728 | 2,723,363 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $24,619,201 | 2,723,363 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $41,040,120 | 2,558,611 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $39,246,741 | 2,502,981 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $27,970,567 | 2,084,245 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||